［1］Warwicker P. Thrombotic microangiopathies and the kidney［J］. Medicine, 2015, 43: 529-532.
［2］张毓文. 溶血尿毒综合征的诊治进展［J］. 实用儿科临床杂志, 2004, 19： 6-11.
［3］易著文, 张辉. 溶血尿毒综合征发病机制及诊治进展［J］. 实用儿科临床杂志, 2011, 26： 1385-1387.
［4］Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations［J］. World J Nephrol, 2013, 2: 56-76.
［5］Pape L, Hartmann H, Bange FC, et al. Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement［J］. Medicine（Baltimore）, 2015, 94: e1000.
［6］El-Ghazal R, Podoltsev N, Marks P, et al. Mitomycin-C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era［J］. Clin Colorectal Cancer, 2011, 10: 142-145.
［7］Malina M, Roumenina LT, Seeman T, et al. Genetics of hemolytic uremic syndromes［J］. Presse Med, 2012, 41: e105-e114.
［8］孟银苹, 付蓉. 补体活化与血栓性微血管病血栓形成关系的研究进展［J］. 中华血液学杂志, 2014, 35： 767-770.
［9］Reese JA, Bougie DW, Curtis BR, et al. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the Blood Center of Wisconsin［J］. Am J Hematol, 2015, 90: 406-410.
［10］Rafiq A, Tariq H, Abbas N, et al. Atypical hemolytic-uremic syndrome: a case report and literature review［J］. Am J Case Rep, 2015, 16: 109-114.
［11］Nester CM, Barbour T, de Cordoba SR, et al. Atypical aHUS: state of the art［J］. Mol Immunol, 2015, 67: 31-42.
［12］Noris M, Remuzzi G. Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: Core Curriculum 2015［J］. Am J Kidney Dis, 2015, 66: 359-375.
［13］符君, 李小平, 王建六. 复发性卵巢癌化疗相关性溶血性尿毒综合征1例(附文献复习)［J］. 肿瘤预防与治疗, 2008, 21： 409-411.
［14］Mannucci PM. Thrombotic microangiopathies: the past as prologue［J］. Eur J Intern Med, 2013, 24: 484-485.
［15］Iams W, Beckermann KE, Neff AT, et al. Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report［J］. Med Oncol, 2013, 30: 568.
［16］Killian M, Bruel Tronchon N, Maillard N, et al. A diagnosis of haemolytic-uraemic syndrome blurred by alcohol abuse［J］. BMJ Case Rep, 2014, pii: bcr 2014205940.
［17］Racca P, Spadi R, Fora G, et al. Hemolytic uremic syndrome induced by infusion of oxaliplatin: a case report［J］. Tumori, 2011, 97: 31e-33e.
［18］Malkhasyan K, Halene S, Lacy J. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer［J］. Clin Colorectal Cancer, 2015, 14: e9-e12.
［19］Dinh A, Anathasayanan A, Rubin LM. Safe and effective use of eculizumab in the treatment of severe Shiga toxin Escherichia coli-associated hemolytic uremic syndrome［J］. Am J Health Syst Pharm, 2015, 72: 117-120.
［20］管娜, 刘晓宇, 姚勇, 等. 抗H因子自身抗体相关性溶血尿毒综合征临床特点、治疗及随访［J］. 中华儿科杂志, 2014, 52： 223-226.